Category
Most Read
Study finds bone injections don't improve survival over IV in cardiac arrest treatment

Study finds bone injections don't improve survival over IV in cardiac arrest treatment

byUniversity of WarwickCredit: Pixabay/CC0 Public DomainAdministrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intrav

Study finds bone injections don't improve survival over IV in cardiac arrest treatment

byUniversity of WarwickCredit: Pixabay/CC0 Public DomainAdministrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intrav
Science-2024 Breakthrough of the Year:The long shot

Science-2024 Breakthrough of the Year:The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.

Science-2024 Breakthrough of the Year:The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.
Today's News
More News
New microscopy technique could enable rapid tumor analysis in the operating room

New microscopy technique could enable rapid tumor analysis in the operating room

byCalifornia Institute of TechnologyThese images show the high resolution achieved with the new microscopy technique. A mouse brain cross-section as seen with photoacoustic imaging is shown in t

New microscopy technique could enable rapid tumor analysis in the operating room

byCalifornia Institute of TechnologyThese images show the high resolution achieved with the new microscopy technique. A mouse brain cross-section as seen with photoacoustic imaging is shown in t
Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3
Treating advanced prostate cancer

Treating advanced prostate cancer

by Nicole Ferrara,Mayo ClinicCredit: Pixabay/CC0 Public DomainAdvanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called metastatic or

Treating advanced prostate cancer

by Nicole Ferrara,Mayo ClinicCredit: Pixabay/CC0 Public DomainAdvanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called metastatic or
Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi
Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1
New treatment target for neuroendocrine prostate cancer discovered

New treatment target for neuroendocrine prostate cancer discovered

by Roswell Park Comprehensive Cancer CenterMitochondria are dysfunctional in neuroendocrine prostate tumors. Credit:Oncogene(2024). DOI: 10.1038/s41388-024-03261-4A team of researchers at

New treatment target for neuroendocrine prostate cancer discovered

by Roswell Park Comprehensive Cancer CenterMitochondria are dysfunctional in neuroendocrine prostate tumors. Credit:Oncogene(2024). DOI: 10.1038/s41388-024-03261-4A team of researchers at
Study links vaginal microbiome differences to higher cervical cancer rates in Native American women

Study links vaginal microbiome differences to higher cervical cancer rates in Native American women

by Lisa Marie Dahm,University of ArizonaVaginal microbiota composition of Native American women in our study. Bar plots show the relative abundance of taxa assigned to the A, genus or B, species

Study links vaginal microbiome differences to higher cervical cancer rates in Native American women

by Lisa Marie Dahm,University of ArizonaVaginal microbiota composition of Native American women in our study. Bar plots show the relative abundance of taxa assigned to the A, genus or B, species
Scientists develop scans that light up aggressive cancer tumors for better treatment

Scientists develop scans that light up aggressive cancer tumors for better treatment

byKing's College London[18F]FSPG PET can differentiate NRF2-high from NRF2-low tumors when grown orthotopically in the lungs of mice. Credit:Nature Communications(2024) DOI: 10.1

Scientists develop scans that light up aggressive cancer tumors for better treatment

byKing's College London[18F]FSPG PET can differentiate NRF2-high from NRF2-low tumors when grown orthotopically in the lungs of mice. Credit:Nature Communications(2024) DOI: 10.1
Neurocognitive battery feasible in 3-year-olds during leukemia treatment

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri
AI model achieves high accuracy in skin cancer detection

AI model achieves high accuracy in skin cancer detection

by TranSpreadThe proposed model architecture. Note: TTA: test-time augmentation. Credit:Data Science and Management(2024). DOI: 10.1016/j.dsm.2024.10.002Led by Aliyu Tetengi Ibrahim and hi

AI model achieves high accuracy in skin cancer detection

by TranSpreadThe proposed model architecture. Note: TTA: test-time augmentation. Credit:Data Science and Management(2024). DOI: 10.1016/j.dsm.2024.10.002Led by Aliyu Tetengi Ibrahim and hi
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Breakthrough in Brain-Machine Interface: Chinese “Thought Communication” Becomes Reality Compared to decoding English’s 26 letters, decoding Chinese with its “418 syllables and 4 tones” presents a higher difficulty. ...